|
Quotes & Info
|
| CEMP > SEC Filings for CEMP > Form 8-K on 4-Oct-2012 | All Recent SEC Filings |
4-Oct-2012
Other Events, Financial Statements and Exhibits
On October 4, 2012, Cempra, Inc. issued a press release announcing positive top-line results from its Phase 2 clinical trial for solithromycin in patients with uncomplicated urogenital gonorrhea. A copy of the press release is attached as Exhibit 99.1.
(d) Exhibits
Exhibit
No. Description
99.1 Press Release issued October 4, 2012.
|
|